C. Brigati et al., A RETINOIC ACID-RESISTANT HL-60 CELL CLONE SENSITIVE TO N-(4-HYDROXYPHENYL) RETINAMIDE-MEDIATED CLONAL GROWTH-INHIBITION, Leukemia & lymphoma, 17(1-2), 1995, pp. 175-180
Among the Retinoic Acid (RA) derivatives, retinamides, and in particul
ar N-(4-hydroxyphenyl) retinamide (4-HPR), are currently being investi
gated in selected cases of cancer chemoprevention. The cellular target
range, however, seems to be limited, as cells of hemopoietic origin a
re virtually incapable of terminal differentiation upon addition of th
e compound. We have reconsidered the effect of 4-HPR on HL-60 cells by
taking advantage of a mutant clone, generated in our laboratory, unre
sponsive to RA but highly responsive to dimethylsulfoxide (DMSO). We s
how here that this clone, upon addition of 4-HPR, although unable of u
ndergoing full differentiation, shows considerable reduction of clonal
growth. Moreover, the combination of 4-HPR and RA resulted in a much
greater effect than the administration of 4-HPR alone. We suggest that
4-HPR and RA, at least in terms of mediating growth inhibition, may f
ollow different metabolic pathways.